Langerhans cell histiocytosis of lymph nodes: Draining a papillary carcinoma of the thyroid

Histopathology

Volumn 30, Issue 6, 1997, Pages 599-603

  Safali, M ^a   McCutcheon, J M ^b   Wright, D H ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Langerhans cell histiocytosis; Papillary carcinoma of thyroid; Phenytoin

Indexed keywords

PHENYTOIN; THYROXINE;

ADULT; ARTICLE; CASE REPORT; EPILEPSY; HISTIOCYTOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; LYMPH NODE; MALE; PRIORITY JOURNAL; THYROID PAPILLARY CARCINOMA;

EID: 0030966566     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1997.5590802.x     Document Type: Article

References (19)

1. Egeler RM, Neglia JP, Puccetti DM, Brennan CA, Nesbit ME. Association of Langerhans cell histocytosis with malignant neoplasms. Cancer 1993; 71; 865-873.
2. Schofield JB, Alsanjari NA, Davis J, MacLenmui KA. Eosinophilic granuloma of lymph nodes associated with metastatic papillary carcinoma of the thyroid. Histopathology 1992; 20; 181-183.
3. Hage C, Willman CL, Favara BE, Isaacson PG. Langerhans cell histiocytosis (histiocytosis X): Immunophenotype and growth fraction. Hum Pathol. 1993; 24; 840-845.
4. Favara BE. Langerhans cell histiocytosis pathobiology and pathogenesis. Semin. Oncol. 1991; 18; 3-7.
5. Willman CL, Busque L, Griffith BB et al. Langerhans cell histiocytosis (histiocytosis X) - A clonal proliferalive disease. N. Eng. J. Med. 1994; 331; 154-160.
6. Mierau GW, Favara BE, Brenman JM. Electronmicroscopy in histiocytosis X. Ultrastruct. Pathol. 1982; 3; 137-142.
7. Ben-Ezra J, Bailey A, Azumi et al. Malignant histiocytosis X: A distinct clinicopathologic entity. Cancer 1991; 68; 1050-1060.
8. Singer J, Schmid C, Souhami R, Isaacson PG. Bone marrow involvement in phenytoin induced 'pseudolymphoma'. Clin. Oncol. 1993; 5: 397-398.
9. Kinane DF, Drummond JR, Chisholm DM. Langerhans cells in human chronic gingivitis and phenytoin induced gingival hyperplasia. Arch. Oral Biol. 1990; 35; 561-564.
10. Burn BF, Colby TV, Dorfman RF. Langerhans cell granulomatosis (histiocytosis X) associated with malignant lymphomas. Am. J. Surg. Pathol 1983; 7; 529-533.
11. Neumann MP, Frizzera G. The coexistence of Langerhans cell granulomatosis and malignant lymphoma may take different forms: Report of seven cases with a review of the literature. Hum. Pathol. 1986; 17; 1060-1065.
12. Richmond I, Eyden BP, Banerjee SS. Intranodal Langerhans cell histiocytosis associated with malignant melanoma. Histopathology 1995; 26; 380-382.
13. Schröder S, Schwarz W, Rehpenning W, Löning T, Böcker W. Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carcinomas. Immunocytochemical study of 106 thyroid neoplasms correlated to follow-up data. Am. J. Clin. Pathol. 1988; 89; 295-300.
14. McLaren KM, Cossar DW. The immunohistochemical localization of S100 in the diagnosis of papillary carcinoma of the thyroid. Hum. Pathol. 1996; 27; 633-636.
15. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF alpha co-operate in the generation of dendritic Langerhans cells. Nature 1992; 360; 258-261.
16. Rosenzwajg M, Canque B, Gluckman JC. Human dendritic cell differentiation pathway from CD 34+ hematopoietic precursor cells. Blood 1996; 87; 535-544.
17. Kannourakis G, Abbas A. The role of cytokines in the pathogenesis of Langerhans cell histiocytosis. Brit. J. Cancer 1994: Suppl. XXIII; 537-40.
18. Hsu SM, Waldron JA, Xie SS, Barlogie B. Expression of interleukin-6 in Castleman's disease. Hum. Pathol 1993; 24; 883-890.
19. Beck JT, Hsu SM, Wijdenes J et al. Alleviation of systemic-manifestations of Castleman's disease by monoclonal interleukin-6 antibody. N. Engl. J. Med. 1994; 330; 602-604.